Search

Your search keyword '"Maria Dolores"' showing total 115 results

Search Constraints

Start Over You searched for: Author "Maria Dolores" Remove constraint Author: "Maria Dolores" Journal international journal of cancer Remove constraint Journal: international journal of cancer
115 results on '"Maria Dolores"'

Search Results

1. Dietary fat, fat subtypes and hepatocellular carcinoma in a large European cohort

2. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations

3. Consumption of fruits, vegetables and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

4. Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: Multicentre, prospective cohort study

5. Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort

6. Anthropometric measures and bladder cancer risk: A prospective study in the EPIC cohort

7. Prediagnostic telomere length and risk of B-cell lymphoma—Results from the EPIC cohort study

8. Risk factors for cancers of unknown primary site: Results from the prospective EPIC cohort

9. Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations

10. Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status—A prospective study within the EPIC cohort

11. Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status—Results from the EPIC cohort

12. Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: Etiological factors or risk markers?

13. Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition

14. Lifetime and baseline alcohol intakes and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition study

15. Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study

16. Genetic variation in the lactase gene, dairy product intake and risk for prostate cancer in the European prospective investigation into cancer and nutrition

17. Tumor necrosis factor (TNF)-α, soluble TNF receptors and endometrial cancer risk: The EPIC study

18. Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition

19. Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition ( EPIC ) cohort

20. Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort

21. Cigar and pipe smoking and cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

22. Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition

23. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations

24. Consumption of fruits, vegetables and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

25. Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition

26. Lifetime and baseline alcohol intake and risk of cancer of the upper aero-digestive tract in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

27. Physical activity and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition Cohort

28. Fish consumption and breast cancer risk. The European Prospective Investigation into Cancer and Nutrition (EPIC)

29. Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: A study within the EPIC cohort

31. Predicted basal metabolic rate and cancer risk in the European Prospective Investigation into Cancer and Nutrition

32. Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer

33. Gallstones and incident colorectal cancer in a large pan‐European cohort study

34. Dietary folate intake and pancreatic cancer risk: Results from the European prospective investigation into cancer and nutrition

35. Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition

36. Pre‐diagnostic circulating insulin‐like growth factor‐I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition

37. Lifetime and baseline alcohol intakes and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition study

38. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations

39. Consumption of fruits, vegetables and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

40. Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

41. Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition

42. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case‐control study

43. Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer

44. Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: Multicentre, prospective cohort study

45. Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort

46. Insulin‐like growth factor I and risk of breast cancer by age and hormone receptor status—A prospective study within the EPIC cohort

47. Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status-Results from the EPIC cohort

48. Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: Etiological factors or risk markers?

49. Genetic variation in the lactase gene, dairy product intake and risk for prostate cancer in the European prospective investigation into cancer and nutrition

50. Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition

Catalog

Books, media, physical & digital resources